Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular ...

Aharon, Ph.D., Co-Founder & CEO of AEYE Health, in conversation with Jake Laznik, Senior Breaking News Desk Manager, The ...

The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched ...

The programme extends across community health centres, taluk hospitals, and district hospitals, making comprehensive eye care ...

Liu: My example falls more in the use of autonomous AI for the detection of referable diabetic retinopathy, which of course includes center-involving DME. At Johns Hopkins Medicine, we started ...

Kerala Govt and Remidio Launch World’s First AI-Powered Govt Screening Program for Chronic Eye Diseases. This pioneering initiative leverages artificial intelligence to enhance early detection and str ...

Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Feb. 12, 2025 — People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually ...

As the researchers note, all but one of the study subjects had a history of type 2 diabetes, and rapid drops in blood sugar like those that occur when taking drugs like Ozempic or Mounjaro ...